Sites / Northwest Cancer Specialists
Is this you?

Request access for Northwest Cancer Specialists with your @compassoncology.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

Northwest Cancer Specialists

Unclaimed profile

Site Network · Vancouver, WA · ~3 sites

Intera lens
ICP 7Lift (cardio sample) 0.10Recruit soph 0.14
Quality Scorecard (1–100)
Overall84Recruit57Ops92Sponsor93Ther99

Performance (observed)

Historical trials
800
Completed
396
Terminated/Withdrawn
104
Completion rate
79%
Active now
276
Phase 2
332
Phase 3
399
Realized enrollment
463,643
First study year
1989
Years active
37
Match confidence
low (approx)
Enrollment velocity (inf)
12,531

Therapeutic

Areas
Oncology, Hematology
Specialties
Comprehensive Oncology (Medical, Surgical, Radiation); Breast Cancer, Blood Disorders
Breadth (conditions)
1,668
Languages
English + Spanish (detected)
States
Oregon, Washington

Recruitment (web observed)

Advertises recruitment
Yes
SEO
Y; blog on cancer clinical trial participation and research
Capability notes
High - Multi-site network with active recruitment

Relationships

Sponsors
National Cancer Institute (NCI); SWOG Cancer Research Network; Alliance for Clinical Trials in Oncology; Pfizer; Novartis Pharmaceuticals; Hoffmann-La Roche
CROs
Fortrea; ICON Clinical Research; IQVIA Pty Ltd; MacroGenics; PRA Health Sciences; Parexel
Partnerships
Sarah Cannon Research Institute (SCRI)
Owner / parent
Unknown
Expansion
Y; East Cancer Center in Happy Valley (40,000 sq ft facility)

Capacity & people

Investigators
Coordinators
CEO
Unknown
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Unknown
Emails
julian.kern@usoncology.com

Tech & DCT

eSource
Yes
Builds tech
Vendors
Tech stack
Electronic health records and standard oncology IT systems
Recruiting visible
Y

Notes

Site Network with 3 locations across OR/WA, part of Compass Oncology network. Governors: David Cosgrove, Jay Andersen, Kathleen Dunham, Lucy Langer, Magdolna Solti, Rob Lufkin, Scott Rushing, Scott Schneider. Practice President Rodney Scott Rushing. ClinicalTrials.gov signal: 9 recruiting trials across 4 locations. Strong recruitment infrastructure, multi-specialty oncology focus. Medium to high Intera fit due to established site network and recruitment capacity.

Recommendation features (sample indication)

Ind fit 0.12Liftability 0.10Overall84

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.